Obesity and arthritis drug study pulled before starting
NCT ID NCT04585711
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 21 times
Summary
This study was designed to learn how body weight changes the way etanercept works in people with rheumatoid arthritis or juvenile idiopathic arthritis who are also obese. Researchers planned to measure drug levels and disease activity in both adults and children starting the medication. However, the study was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke University Medical Center
Durham, North Carolina, 27705, United States
Conditions
Explore the condition pages connected to this study.